Michael Tokich

As Chief Financial Officer, Michael Tokich has primary responsibility for Financial Reporting, Financial Planning and Analysis, Investor Relations, Information Technology, Internal Audit, Business Development, Strategic Planning, Operations Finance, Tax, Treasury, Risk Management, Regulatory Affairs, Quality, and Regulatory Compliance, Facilities, Communications, Government Relations, and Health Safety and Environmental. He joined STERIS in May 2000 as Assistant Corporate Controller and became Vice President, Corporate Controller in December 2000. He became Senior Vice President and Chief Financial Officer in March 2008 after serving as interim Chief Financial Officer since December 2006. Mr. Tokich also assumed the role of Treasurer from February 2014 through July 2017 and was the company’s Chief Accounting Officer from December 2006 through October 2016 in addition to his other responsibilities. 

Since joining STERIS, he has played a key role in significantly strengthening the company’s balance sheet, improving the company’s free cash flow generation, and enhancing shareholder value. In addition, he has streamlined the financial reporting processes and procedures through increased automation, policy deployment, and oversight. He has been instrumental in overseeing the growth of the company via acquisitions and fostered the re-domiciliation of the company to the United Kingdom after the combination of the $2.3 billion acquisition of Synergy Health plc. in November 2015. In March 2019, STERIS re-domiciled to Ireland to preserve the current and future benefits initially established in 2015 at the time of the combination with Synergy Health plc.